Maria Dolores
Chirlaque Lopez
Asociado a Tiempo Parcial
![Foto de Stanisław Sław S.](/img/nophoto.png)
Stanisław Sław S.
Gõźdź
Publicaciones en las que colabora con Stanisław Sław S. Gõźdź (39)
2021
-
The histology of brain tumors for 67 331 children and 671 085 adults diagnosed in 60 countries during 2000-2014: a global, population-based study (CONCORD-3)
Neuro-Oncology, Vol. 23, Núm. 10, pp. 1765-1776
2020
-
Reasons for low cervical cancer survival in new accession European Union countries: a EUROCARE-5 study
Archives of Gynecology and Obstetrics, Vol. 301, Núm. 2, pp. 591-602
2018
2017
-
Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)
Gynecologic Oncology
-
Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)
Gynecologic Oncology
-
Geographical variability in survival of European children with central nervous system tumours
European Journal of Cancer, Vol. 82, pp. 137-148
-
Survival of 86,690 patients with thyroid cancer: A population-based study in 29 European countries from EUROCARE-5
European Journal of Cancer, Vol. 77, pp. 140-152
-
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)
Gynecologic Oncology, Vol. 144, Núm. 2, pp. 405-413
-
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)
Gynecologic Oncology, Vol. 144, Núm. 2, pp. 396-404
-
Worldwide comparison of survival from childhood leukaemia for 1995–2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89 828 children from 198 registries in 53 countries
The Lancet Haematology, Vol. 4, Núm. 5, pp. e202-e217
2015
-
Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2120-2129
-
Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
The Lancet, Vol. 385, Núm. 9972, pp. 977-1010
-
Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2130-2143
-
Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2144-2157
-
Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2206-2216
-
The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2104-2119
-
Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5
European Journal of Cancer, Vol. 51, Núm. 15, pp. 2217-2230
2014
-
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study
The Lancet Oncology, Vol. 15, Núm. 1, pp. 23-34
-
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project
Cancer Epidemiology, Vol. 38, Núm. 6, pp. 670-678
2013
-
Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project
European Journal of Cancer, Vol. 49, Núm. 3, pp. 684-695